Human FGF-3 Antibody Summary
-15 is observed.
Accession # P11487
Complete Your Research
Complete Your Experiment
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Cell Proliferation Induced by FGF‑3 and Neutralization by Human FGF‑3 Antibody. Recombinant Human FGF-3 (Catalog # 1206-F3) stimulates proliferation in the the NR6R-3T3 mouse fibroblast cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human FGF-3 (0.3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human FGF-3 Monoclonal Antibody (Catalog # MAB1206). The ND50 is typically 2-5 µg/mL in the presence of heparin (1 µg/mL).
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Fibroblast Growth Factor 3 (FGF-3) belongs to the large FGF family which has at least 23 members (1, 2). All FGF family members are heparin-binding growth factors with a core 120 amino acid (aa) FGF domain that allows for a common tertiary structure. FGFs are expressed during embryonic development and in restricted adult tissues. They act on cells of mesodermal and neuroectodermal origin to regulate diverse physiologic functions including angiogenesis, cell growth, pattern formation, embryonic development, metabolic regulation, cell migration, neurotrophic effects and tissue repair (3, 4). Signaling receptors for FGFs are type I transmembrane receptor tyrosine kinases belonging to the Ig superfamily. Four distinct but related classes of FGF receptors, FGF R1, 2, 3, and 4, exist. Through alternative splicing, multiple isoforms for FGF R1, 2 and 3, with distinct ligand recognition profiles, are also generated (4).
The FGF-3 gene, originally designated int-2, was first identified as a proto-oncogene activated in mouse mammary tumors by proviral integration (2). Amplification of this gene has also been found frequently in human tumors. Human FGF-3 cDNA predicts a 239 aa precursor protein with a 17 aa signal peptide and a 222 aa secreted mature protein with one potential N-linked glycosylation site (1). Human and mouse FGF-3 share 88% aa sequence identity. The Xenopus and mammalian secreted FGF-3 are processed proteolytically at both the N- and C-terminus (5). FGF-3 binds with high-affinity to the IIIb isoforms of FGF R1 and FGF R2. FGF-3 also binds the IIIc isoform of FGF R2, but with lower affinity (6). FGF-3 has been implicated in the induction of inner ear development (7). Studies have suggested that FGF-3 and FGF-8 function synergistically in otic placode induction and during neuronal development to regulate dorsoventral axis formation (8 - 10). During development, the activities of FGF-3 and FGF-8 are regulated negatively by the sprouty family proteins and by Sef (similar expression to fgf genes), a transmebrane protein that shares intracellular sequence similarities with the IL-17 receptor (10).
Brookes, S. et al. (1989) Oncogene 4:429.
Dickson, C. et al. (1989) Prog. Growth Factor Res. 1:123.
Goldfarb, M. (1996) Cytokine and Growth Factor Reviews 7:311.
Green, P. et al. (1996) BioEssays 18:639.
Antoine, M. et al. (2000) Cell Growth Differen. 11:593.
Kohl, R. et al. (2002) J. Biol. Chem. 277:32760.
- Represa, J. et al. (1991) Nature 353:561.
- Maroon, H. et al. (2002) Development, 129:2099.
- Walshe, J. et al. (2002) Current Biol. 12:1117.
- Furthauer, M. et al. (2002) Nature Cell Biol. 4:170.
Citations for Human FGF-3 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
Citations: Showing 1 - 2
Filter your results:
A single-step, high-dose selection scheme reveals distinct mechanisms of acquired resistance to oncogenic kinase inhibition in cancer cells
Authors: KJ Finn, SE Martin, J Settleman
Cancer Res., 2019;0(0):.
Fractional CO2 laser: a novel therapeutic device upon photobiomodulation of tissue remodeling and cytokine pathway of tissue repair.
Authors: Prignano F, Campolmi P, Bonan P
Dermatol Ther, 2009;22(0):S8-15.
Sample Types: Whole Tissue
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human FGF-3 Antibody
There are currently no reviews for this product. Be the first to review Human FGF-3 Antibody and earn rewards!
Have you used Human FGF-3 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image